Home » News » Nora Kronig – Swiss vaccination strategist on TV talk: “Ms. Kronig, did Switzerland buy too few vaccines too late?”

Nora Kronig – Swiss vaccination strategist on TV talk: “Ms. Kronig, did Switzerland buy too few vaccines too late?”

“We are on course”: Nora Kronig is confident. Your most important statements in the “TalkTaily” program on Wednesday evening.

CH Media

Swiss vaccination strategist on TV talk: “Ms. Kronig, did Switzerland buy too few vaccines too late?”

It is hotly debated these days: the federal vaccination strategy. Too little, too late, is the most common criticism. Nora Kronig, Vice Director of the Federal Office of Public Health and responsible for the vaccination strategy, is surprisingly confident in the TalkTaily of the CH Media TV station.

(we are)

Do. That seems to be Nora Kronig’s credo. Every day she is confronted with new problems that need to be prevented or solved, she says. Even when asked how she can calm down on such a demanding task, she answers:

«In doing, in solving problems, in being confident that you are making progress. In doing so, working in a team to find the best way to find the best solution. “

While there is always criticism of her vaccination strategy, Nora Kronig, Vice Director of the Federal Office of Public Health, is not to be disturbed this Wednesday in the TV studio either. “We are on course, we are making progress,” she says more than once. She seems calm, serene and confident.

She is confident that all Swiss people who want to be vaccinated can be vaccinated by the end of June:

“Our delivery schedules up to the summer are oriented in such a way that we can achieve the goals that we have set ourselves.”

When it comes to the details, she answers rather evasively. Regarding the fact that the vaccine from Astra Zeneca does not appear in the plans of the federal government and when asked whether it should be vaccinated in Switzerland, she says: “It is an ongoing plan and we are counting on all possibilities.”

Regarding the vaccine from Johnson & Johnson, which was recently approved without Switzerland having already ordered it, she refers to the timing: “That came at a time that is later in this sense, but we are still open about procurement . “

“Do you share the criticism that people were too reluctant to procure?” asks moderator Oliver Steffen. Kronig: “We knew that we had to reckon with a first quarter of shortages. Why? Because you have to build this production capacity in the private sector. ” “Very large quantities” of vaccine would then be available in a second quarter. Faster emergency approvals would not be practiced in Switzerland, nor would health data be shared as in Israel.

“We were among the first to sign a contract with Moderna, I think they really tried to achieve quick access to the best vaccines for the Swiss population. We wanted to be on time with Europe, to be the fastest was never a goal. “

«I hear zero self-criticism»,

twice after Steffen. Would the critics simply be wrong? Kronig: “I believe that you have to be aware of the limits when it comes to what can be achieved in vaccine production and distribution. You have to reckon with a shortage at the beginning and the question is how to deal with it. “

And yet: «Nobody is made of Teflon. Does this criticism also meet you sometimes? ”Asks Steffen. “You have to be able to deal with criticism when you have such a responsibility,” says Kronig. Your strategy: keep going, stay tuned, make the best of it.

The full length of the “TalkTaily” program on Wednesday evening with Nora Kronig:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.